Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

Since 2011, the approval of 108 immuno-oncology(I-O) products have radically changed the cancer treatment landscape and the clinical trial pipeline. Rapid development of promising I-O therapies represents the greatest opportunity for cancer patients, but future progress is severely threatened by persistent challenges in clinical research.